人ごとではない婦人科がんを知ろう

Item: 人ごとではない婦人科がんを知ろう
Rating: 4
Author: PostSingularity Institute

by Masaki Mandai (Professor, Kyoto University)

Life & Natural Systems Medicine & Health VFJBCoping with VFJB3Coping with

🎙 Masaki Mandai (Professor, Kyoto University) 👥 5K 📅 February 19, 2026 ⏱ 15 min 👁 454 📄 science communication 🧭 2026-08-16

Available in: English (current) Français

Keywords

cervical cancerHPVvaccineovarian cancerendometrial cancer

Summary

The video is a recorded lecture from the 14th Cancer Specialist Direct Live event, presented by Professor Masaki Mandai from Kyoto University. It aims to educate the public about gynecological cancers, emphasizing that they are not a distant concern. The lecture covers the three major types: cervical, endometrial (uterine body), and ovarian cancers, which together account for 97% of gynecological cancers. For each, it discusses incidence, mortality, causes, symptoms, and treatment options. Cervical cancer is highlighted as a young-age cancer caused by HPV, with a vaccine available for prevention. Endometrial cancer is linked to hormonal imbalances and often presents with abnormal bleeding, leading to early detection. Ovarian cancer is more challenging to detect early due to its location, resulting in higher mortality. The speaker stresses the importance of regular screening, accurate information, and shared decision-making with doctors. He also addresses the concerning rise in cervical cancer in Japan due to a decade-long suspension of HPV vaccine recommendations, contrasting with global declines. The lecture concludes with advice for patients: don’t panic, avoid optimism bias, and seek correct initial treatment. Resources are available on the Japanese Cancer Society’s website.

187 words

Critical Evaluation

Value of the Information & Strength of the Argument

The video provides valuable information on gynecological cancers, with clear explanations of each cancer type, their risk factors, and treatment modalities. The speaker uses relatable analogies (e.g., comparing cervical cancer deaths to the Hanshin earthquake) to emphasize the impact. The argumentation is solid, grounded in established medical knowledge and statistics. The speaker also addresses the HPV vaccine controversy in Japan, providing a balanced view on its effectiveness and the current situation. The inclusion of a surgical video clip adds practical insight, though it may be graphic for some viewers.

Scientific Rigor, Source Quality, Title Accuracy

The scientific rigor is high, as the speaker is a professor and the content aligns with current medical guidelines. The video references the Japanese Cancer Society’s website for further information, which is a credible source. However, specific studies or data sources are not cited in the video. The title accurately reflects the content, which is a public education lecture. No comments were provided, so no analysis of public reception is possible.

175 words

Title / Content Match

The title accurately reflects the content, which aims to raise awareness about gynecological cancers.

Quality & Reliability

8/10

The video is presented by a professor of gynecology and obstetrics at Kyoto University, and the content aligns with established medical knowledge. The speaker provides statistics and references to official society resources, but the video is a recorded lecture without peer review or detailed citations.

Key Moments

Markers derived by PSI from the transcript: the creator did not define chapters.

Cited Sources

認定がんナビ制度 (Certified Cancer Navigator System) — Mentioned in the video description as a resource for cancer information.

Concurring Sources

WHO fact sheet on HPV and cervical cancer — Supports the claim that HPV causes cervical cancer and that vaccines are effective.

Contribution & Novelties

The video provides a comprehensive overview of gynecological cancers, emphasizing the importance of HPV vaccination and early detection. It uniquely highlights the situation in Japan, where cervical cancer is increasing despite global declines, due to the suspension of vaccine recommendations. The speaker’s personal experience with immunotherapy trials for ovarian cancer adds a novel perspective.

Pour aller plus loin :

HPV vaccine and cervical cancer prevention — WHO fact sheet on HPV and cervical cancer.
Robotic surgery in gynecologic oncology — Review of robotic surgery applications.
Immunotherapy in ovarian cancer — NCI overview of ovarian cancer treatment, including immunotherapy.

98 words

Radar Profile

The radar profile shows high scores in quality and reliability, with moderate scores in quantity and technical level. This indicates a well-informed but not overly technical presentation, suitable for a general audience.

Reliability 8/10